Skip to main content
Nicholas Stanzione, MD, Pathology, Los Angeles, CA

NicholasStanzioneMD

Pathology • Los Angeles, CA

Cytopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Stanzione is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stanzione's full profile

Already have an account?

  • Office

    10833 Le Conte Ave
    As370 CHS
    Los Angeles, CA 90095
    Phone+1 310-267-2680
    Fax+1 310-267-2685

Summary

  • AP/CP Board Certified

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Cytopathology, 2020 - 2021
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pathology-Anatomic and Clinical, 2016 - 2020
  • Commonwealth Medical College
    Commonwealth Medical CollegeClass of 2016, MD
  • New York University
    New York UniversityBachelor of Arts, 2007 - 2011

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2018 - 2025
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Cytopathology

Publications & Presentations

PubMed

Press Mentions

  • UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
    UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer RecurrenceApril 4th, 2024
  • UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
    UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer RecurrenceApril 5th, 2024

Professional Memberships

Dr. Nicholas Stanzione, Dr. Nicholas Stanzione, MD, Dr. N Stanzione